Tirzepatide 10mg

VIOGEN Tirzepatide 10mg is a medication that mimics the hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are involved in blood sugar regulation and appetite control. It is approved for the treatment of type 2 diabetes and for weight loss. Tirzepatide has been shown to help people lose weight by mimicking hormones that lower blood sugar and curb appetite. In clinical trials, tirzepatide led to an average weight loss of 16% over 16 months in individuals with obesity or overweight and type 2 diabetes.

VIOGEN Tirzepatide is part of a new class of drugs called GLP-1 receptor agonists that were developed to treat type 2 diabetes and obesity.

Tirzepatide has been associated with side effects such as nausea, vomiting, diarrhea, abdominal pain, constipation, allergic reactions, acute kidney injury, pancreatitis, gallbladder problems, diabetic retinopathy, and behavioral changes.

• Active Substance: Tirzepatide
• Presentation: 10mg/vial and bacteriostatic water (2ml)